SUMO-modified nuclear cyclin D1 bypasses Ras-induced senescence

X D Wang1, E Lapi, A Sullivan

  • 1Nuffield Department of Clinical Medicine, Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK.

Insights

Apoptosis-stimulating protein of p53 (ASPP) 2 suppresses Ras-induced senescence via a novel pathway. This study reveals SUMO modification as a key regulator of nuclear cyclin D1, impacting cell cycle entry and senescence.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Oncogene-induced senescence is a critical tumor suppressive mechanism.
  • The tumor suppressor apoptosis-stimulating protein of p53 (ASPP) 2 is a recently identified protein involved in cellular processes.

Purpose of the Study:

  • To investigate the role of ASPP2 in Ras oncogene-induced senescence.
  • To elucidate the novel p53/p19(Arf)/p21(waf1/cip1)-independent pathway mediated by ASPP2.
  • To identify new regulators of cell cycle entry and senescence.

Main Methods:

  • Investigated Ras oncogene-induced senescence.
  • Analyzed the role of ASPP2 in regulating nuclear cyclin D1 and retinoblastoma protein (Rb) phosphorylation.
  • Examined the effect of SUMO modification on cyclin D1.
  • Compared the potency of nuclear cyclin D1 versus wild-type (WT) cyclin D1 in bypassing senescence.

Main Results:

  • ASPP2 mediates Ras oncogene-induced senescence through a novel pathway independent of p53/p19(Arf)/p21(waf1/cip1).
  • ASPP2 suppresses small ubiquitin-like modifier (SUMO)-modified nuclear cyclin D1 and inhibits Rb phosphorylation.
  • Lysine residue K33 of cyclin D1 is crucial for this regulation.
  • Nuclear cyclin D1 is more potent than WT cyclin D1 in bypassing Ras-induced senescence.

Conclusions:

  • SUMO modification positively regulates nuclear cyclin D1.
  • ASPP2 acts as a tumor suppressor by inhibiting nuclear cyclin D1 and Rb phosphorylation.
  • A new mechanism regulating cell cycle entry and senescence involving SUMO modification of cyclin D1 is identified.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...